Cargando…
Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation
Background: This study aimed to evaluate the role of plasma microRNA panel (miR-122, miR-192, miR-21, miR-223, miR-26a, miR-27a and miR-801) for prediction and surveillance of early tumor recurrence in hepatocellular carcinoma (HCC) patients who had undergone liver transplantation (LT). Methods: The...
Autores principales: | Huang, Ao, Guo, De-Zhen, Wang, Yu-Peng, Yang, Guo-Huan, Sun, Qi-Man, Zhang, Xin, He, Yi-Feng, Song, Kang, Huang, Xiao-Wu, Yang, Xin-Rong, Fan, Jia, Zhou, Jian, Hu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558660/ https://www.ncbi.nlm.nih.gov/pubmed/34729120 http://dx.doi.org/10.7150/jca.59612 |
Ejemplares similares
-
Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
por: Hu, Jie, et al.
Publicado: (2011) -
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
por: Guo, De-Zhen, et al.
Publicado: (2022) -
Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma
por: An, Yang, et al.
Publicado: (2018) -
MicroRNA-424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation
por: Wu, Liming, et al.
Publicado: (2018) -
Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2017)